| This Week’s News | A serious issue with esophagogastric balloon tamponade tubes manufactured by BD could cause the devices to break, potentially delaying care for bleeding patients. Clinicians are advised to review and follow updated use instructions. A serious issue with esophagogastric balloon tamponade tubes manufactured by BD could cause the devices to break, potentially delaying care for bleeding patients. Clinicians are advised to review and follow updated use instructions. | | |
| The shift follows a paper published by the FDA in the New England Journal of Medicine last week, outlining a stricter framework for approving annual COVID-19 boosters and future vaccines. The shift follows a paper published by the FDA in the New England Journal of Medicine last week, outlining a stricter framework for approving annual COVID-19 boosters and future vaccines. | | |
| A lack of Medicare reimbursement is just one issue. In a national survey, home healthcare agencies report dropping telemedicine offerings because elderly patients tend to prefer in-person care. A lack of Medicare reimbursement is just one issue. In a national survey, home healthcare agencies report dropping telemedicine offerings because elderly patients tend to prefer in-person care. | | |
| Walmart is highlighting food and products eligible for purchase using Medicare Advantage supplemental funds through its app, while also using AI to algorithmically help enrollees build diet-appropriate shopping lists. Walmart is highlighting food and products eligible for purchase using Medicare Advantage supplemental funds through its app, while also using AI to algorithmically help enrollees build diet-appropriate shopping lists. | | |
| The analysis—required under an executive order from President Donald Trump—lists overmedicalization, excessive screen time, processed foods and environmental toxins as contributing factors for everything from cancer to ADHD. The analysis—required under an executive order from President Donald Trump—lists overmedicalization, excessive screen time, processed foods and environmental toxins as contributing factors for everything from cancer to ADHD. | | |
| This is the second time Mark Linskey, MD, has been awarded a judgement. He claims UC Irvine kicked him out of a residency program when he reported patient safety concerns and multiple incidents of waste at the academic health system. This is the second time Mark Linskey, MD, has been awarded a judgement. He claims UC Irvine kicked him out of a residency program when he reported patient safety concerns and multiple incidents of waste at the academic health system. | | |
| The billionaire CEO of Tesla said his time serving in an official capacity in the Trump administration is at an end, though he will remain an advisor. The billionaire CEO of Tesla said his time serving in an official capacity in the Trump administration is at an end, though he will remain an advisor. | | |
| The Digital Medicine Society has partnered with organizations such as Duke University and Google Fitbit to leverage wearable technology and smartphone data in reducing opioid relapse and overdose deaths. As the pilot study gets underway, HealthExec speaks with Candice Taguibao, associate program director at the Digital Medicine Society, to learn more about the initiative. The Digital Medicine Society has partnered with organizations such as Duke University and Google Fitbit to leverage wearable technology and smartphone data in reducing opioid relapse and overdose deaths. As the pilot study gets underway, HealthExec speaks with Candice Taguibao, associate program director at the Digital Medicine Society, to learn more about the initiative. | | |
| The lawsuits, filed in multiple states, contend there's a causal link between semaglutide and a rare condition called NAION that leads to diminished eyesight. Plaintiffs want the popular weight-loss drugs to add a warning label. The lawsuits, filed in multiple states, contend there's a causal link between semaglutide and a rare condition called NAION that leads to diminished eyesight. Plaintiffs want the popular weight-loss drugs to add a warning label. | | |
| |
|
| ![]() | |
|
